Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Supply, Demand and Key Producers, 2023-2029
The global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine is a vaccine for the prevention and treatment of porcine infectious diarrhea and gastroenteritis.
This report studies the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine total production and demand, 2018-2029, (K Units)
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine total production value, 2018-2029, (USD Million)
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine domestic production, consumption, key domestic manufacturers and share
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CAVAC, Green Cross Veterinary Products, Harrisvaccines, Komipharm, Nisseiken, Qilu Animal Health, Zoetis, Wuhan Keqian and China Animal Husbandry Industry, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market, By Region:
1. How big is the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market?
2. What is the demand of the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market?
3. What is the year over year growth of the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market?
4. What is the production and production value of the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market?
5. Who are the key producers in the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market?
6. What are the growth factors driving the market demand?
Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine is a vaccine for the prevention and treatment of porcine infectious diarrhea and gastroenteritis.
This report studies the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine total production and demand, 2018-2029, (K Units)
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine total production value, 2018-2029, (USD Million)
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine domestic production, consumption, key domestic manufacturers and share
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CAVAC, Green Cross Veterinary Products, Harrisvaccines, Komipharm, Nisseiken, Qilu Animal Health, Zoetis, Wuhan Keqian and China Animal Husbandry Industry, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Live Vaccine
- Inactivated Vaccine
- Piglet
- Adult Pig
- CAVAC
- Green Cross Veterinary Products
- Harrisvaccines
- Komipharm
- Nisseiken
- Qilu Animal Health
- Zoetis
- Wuhan Keqian
- China Animal Husbandry Industry
- Luoyang Huizhong
- Shanghai Hile Bio-Technology
- Harbin Weike
- Harbin Pharmaceutical Group
- Jiangsu Nannong
1. How big is the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market?
2. What is the demand of the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market?
3. What is the year over year growth of the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market?
4. What is the production and production value of the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market?
5. Who are the key producers in the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Introduction
1.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Supply & Forecast
1.2.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029)
1.2.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Pricing Trends (2018-2029)
1.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region (Based on Production Site)
1.3.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Region (2018-2029)
1.3.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region (2018-2029)
1.3.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Region (2018-2029)
1.3.4 North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029)
1.3.5 Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029)
1.3.6 China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029)
1.3.7 Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Demand (2018-2029)
2.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption by Region
2.2.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption by Region (2018-2023)
2.2.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.4 China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.5 Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.6 Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.7 South Korea Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.8 ASEAN Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.9 India Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
3 WORLD PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Manufacturer (2018-2023)
3.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Manufacturer (2018-2023)
3.4 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine in 2022
3.6 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Overall Company Footprint Analysis
3.6.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Region Footprint
3.6.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Company Product Type Footprint
3.6.3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Comparison
4.1.1 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Comparison
4.2.1 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Comparison
4.3.1 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023)
4.5 China Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers and Market Share
4.5.1 China Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023)
4.6 Rest of World Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Live Vaccine
5.2.2 Inactivated Vaccine
5.3 Market Segment by Type
5.3.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Type (2018-2029)
5.3.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Type (2018-2029)
5.3.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Piglet
6.2.2 Adult Pig
6.3 Market Segment by Application
6.3.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Application (2018-2029)
6.3.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Application (2018-2029)
6.3.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 CAVAC
7.1.1 CAVAC Details
7.1.2 CAVAC Major Business
7.1.3 CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.1.4 CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 CAVAC Recent Developments/Updates
7.1.6 CAVAC Competitive Strengths & Weaknesses
7.2 Green Cross Veterinary Products
7.2.1 Green Cross Veterinary Products Details
7.2.2 Green Cross Veterinary Products Major Business
7.2.3 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.2.4 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Green Cross Veterinary Products Recent Developments/Updates
7.2.6 Green Cross Veterinary Products Competitive Strengths & Weaknesses
7.3 Harrisvaccines
7.3.1 Harrisvaccines Details
7.3.2 Harrisvaccines Major Business
7.3.3 Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.3.4 Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Harrisvaccines Recent Developments/Updates
7.3.6 Harrisvaccines Competitive Strengths & Weaknesses
7.4 Komipharm
7.4.1 Komipharm Details
7.4.2 Komipharm Major Business
7.4.3 Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.4.4 Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Komipharm Recent Developments/Updates
7.4.6 Komipharm Competitive Strengths & Weaknesses
7.5 Nisseiken
7.5.1 Nisseiken Details
7.5.2 Nisseiken Major Business
7.5.3 Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.5.4 Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Nisseiken Recent Developments/Updates
7.5.6 Nisseiken Competitive Strengths & Weaknesses
7.6 Qilu Animal Health
7.6.1 Qilu Animal Health Details
7.6.2 Qilu Animal Health Major Business
7.6.3 Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.6.4 Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Qilu Animal Health Recent Developments/Updates
7.6.6 Qilu Animal Health Competitive Strengths & Weaknesses
7.7 Zoetis
7.7.1 Zoetis Details
7.7.2 Zoetis Major Business
7.7.3 Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.7.4 Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Zoetis Recent Developments/Updates
7.7.6 Zoetis Competitive Strengths & Weaknesses
7.8 Wuhan Keqian
7.8.1 Wuhan Keqian Details
7.8.2 Wuhan Keqian Major Business
7.8.3 Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.8.4 Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Wuhan Keqian Recent Developments/Updates
7.8.6 Wuhan Keqian Competitive Strengths & Weaknesses
7.9 China Animal Husbandry Industry
7.9.1 China Animal Husbandry Industry Details
7.9.2 China Animal Husbandry Industry Major Business
7.9.3 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.9.4 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 China Animal Husbandry Industry Recent Developments/Updates
7.9.6 China Animal Husbandry Industry Competitive Strengths & Weaknesses
7.10 Luoyang Huizhong
7.10.1 Luoyang Huizhong Details
7.10.2 Luoyang Huizhong Major Business
7.10.3 Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.10.4 Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Luoyang Huizhong Recent Developments/Updates
7.10.6 Luoyang Huizhong Competitive Strengths & Weaknesses
7.11 Shanghai Hile Bio-Technology
7.11.1 Shanghai Hile Bio-Technology Details
7.11.2 Shanghai Hile Bio-Technology Major Business
7.11.3 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.11.4 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Shanghai Hile Bio-Technology Recent Developments/Updates
7.11.6 Shanghai Hile Bio-Technology Competitive Strengths & Weaknesses
7.12 Harbin Weike
7.12.1 Harbin Weike Details
7.12.2 Harbin Weike Major Business
7.12.3 Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.12.4 Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Harbin Weike Recent Developments/Updates
7.12.6 Harbin Weike Competitive Strengths & Weaknesses
7.13 Harbin Pharmaceutical Group
7.13.1 Harbin Pharmaceutical Group Details
7.13.2 Harbin Pharmaceutical Group Major Business
7.13.3 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.13.4 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.13.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.14 Jiangsu Nannong
7.14.1 Jiangsu Nannong Details
7.14.2 Jiangsu Nannong Major Business
7.14.3 Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.14.4 Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Jiangsu Nannong Recent Developments/Updates
7.14.6 Jiangsu Nannong Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Chain
8.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Upstream Analysis
8.2.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Mode
8.6 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Procurement Model
8.7 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Sales Model and Sales Channels
8.7.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Model
8.7.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Introduction
1.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Supply & Forecast
1.2.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029)
1.2.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Pricing Trends (2018-2029)
1.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region (Based on Production Site)
1.3.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Region (2018-2029)
1.3.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region (2018-2029)
1.3.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Region (2018-2029)
1.3.4 North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029)
1.3.5 Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029)
1.3.6 China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029)
1.3.7 Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Demand (2018-2029)
2.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption by Region
2.2.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption by Region (2018-2023)
2.2.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.4 China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.5 Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.6 Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.7 South Korea Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.8 ASEAN Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
2.9 India Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029)
3 WORLD PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Manufacturer (2018-2023)
3.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Manufacturer (2018-2023)
3.4 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine in 2022
3.6 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Overall Company Footprint Analysis
3.6.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Region Footprint
3.6.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Company Product Type Footprint
3.6.3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Comparison
4.1.1 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Comparison
4.2.1 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Comparison
4.3.1 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023)
4.5 China Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers and Market Share
4.5.1 China Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023)
4.6 Rest of World Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Live Vaccine
5.2.2 Inactivated Vaccine
5.3 Market Segment by Type
5.3.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Type (2018-2029)
5.3.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Type (2018-2029)
5.3.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Piglet
6.2.2 Adult Pig
6.3 Market Segment by Application
6.3.1 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Application (2018-2029)
6.3.2 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Application (2018-2029)
6.3.3 World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 CAVAC
7.1.1 CAVAC Details
7.1.2 CAVAC Major Business
7.1.3 CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.1.4 CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 CAVAC Recent Developments/Updates
7.1.6 CAVAC Competitive Strengths & Weaknesses
7.2 Green Cross Veterinary Products
7.2.1 Green Cross Veterinary Products Details
7.2.2 Green Cross Veterinary Products Major Business
7.2.3 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.2.4 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Green Cross Veterinary Products Recent Developments/Updates
7.2.6 Green Cross Veterinary Products Competitive Strengths & Weaknesses
7.3 Harrisvaccines
7.3.1 Harrisvaccines Details
7.3.2 Harrisvaccines Major Business
7.3.3 Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.3.4 Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Harrisvaccines Recent Developments/Updates
7.3.6 Harrisvaccines Competitive Strengths & Weaknesses
7.4 Komipharm
7.4.1 Komipharm Details
7.4.2 Komipharm Major Business
7.4.3 Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.4.4 Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Komipharm Recent Developments/Updates
7.4.6 Komipharm Competitive Strengths & Weaknesses
7.5 Nisseiken
7.5.1 Nisseiken Details
7.5.2 Nisseiken Major Business
7.5.3 Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.5.4 Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Nisseiken Recent Developments/Updates
7.5.6 Nisseiken Competitive Strengths & Weaknesses
7.6 Qilu Animal Health
7.6.1 Qilu Animal Health Details
7.6.2 Qilu Animal Health Major Business
7.6.3 Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.6.4 Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Qilu Animal Health Recent Developments/Updates
7.6.6 Qilu Animal Health Competitive Strengths & Weaknesses
7.7 Zoetis
7.7.1 Zoetis Details
7.7.2 Zoetis Major Business
7.7.3 Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.7.4 Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Zoetis Recent Developments/Updates
7.7.6 Zoetis Competitive Strengths & Weaknesses
7.8 Wuhan Keqian
7.8.1 Wuhan Keqian Details
7.8.2 Wuhan Keqian Major Business
7.8.3 Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.8.4 Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Wuhan Keqian Recent Developments/Updates
7.8.6 Wuhan Keqian Competitive Strengths & Weaknesses
7.9 China Animal Husbandry Industry
7.9.1 China Animal Husbandry Industry Details
7.9.2 China Animal Husbandry Industry Major Business
7.9.3 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.9.4 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 China Animal Husbandry Industry Recent Developments/Updates
7.9.6 China Animal Husbandry Industry Competitive Strengths & Weaknesses
7.10 Luoyang Huizhong
7.10.1 Luoyang Huizhong Details
7.10.2 Luoyang Huizhong Major Business
7.10.3 Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.10.4 Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Luoyang Huizhong Recent Developments/Updates
7.10.6 Luoyang Huizhong Competitive Strengths & Weaknesses
7.11 Shanghai Hile Bio-Technology
7.11.1 Shanghai Hile Bio-Technology Details
7.11.2 Shanghai Hile Bio-Technology Major Business
7.11.3 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.11.4 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Shanghai Hile Bio-Technology Recent Developments/Updates
7.11.6 Shanghai Hile Bio-Technology Competitive Strengths & Weaknesses
7.12 Harbin Weike
7.12.1 Harbin Weike Details
7.12.2 Harbin Weike Major Business
7.12.3 Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.12.4 Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Harbin Weike Recent Developments/Updates
7.12.6 Harbin Weike Competitive Strengths & Weaknesses
7.13 Harbin Pharmaceutical Group
7.13.1 Harbin Pharmaceutical Group Details
7.13.2 Harbin Pharmaceutical Group Major Business
7.13.3 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.13.4 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.13.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.14 Jiangsu Nannong
7.14.1 Jiangsu Nannong Details
7.14.2 Jiangsu Nannong Major Business
7.14.3 Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
7.14.4 Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Jiangsu Nannong Recent Developments/Updates
7.14.6 Jiangsu Nannong Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Chain
8.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Upstream Analysis
8.2.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Mode
8.6 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Procurement Model
8.7 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Sales Model and Sales Channels
8.7.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Model
8.7.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share by Region (2018-2023)
Table 9. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share by Region (2024-2029)
Table 10. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Market Trends
Table 13. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Producers in 2022
Table 18. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Producers in 2022
Table 20. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Company Evaluation Quadrant
Table 22. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Site of Key Manufacturer
Table 24. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Company Product Type Footprint
Table 25. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Company Product Application Footprint
Table 26. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Competitive Factors
Table 27. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine New Entrant and Capacity Expansion Plans
Table 28. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share (2018-2023)
Table 37. China Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share (2018-2023)
Table 47. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. CAVAC Basic Information, Manufacturing Base and Competitors
Table 62. CAVAC Major Business
Table 63. CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 64. CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. CAVAC Recent Developments/Updates
Table 66. CAVAC Competitive Strengths & Weaknesses
Table 67. Green Cross Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 68. Green Cross Veterinary Products Major Business
Table 69. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 70. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Green Cross Veterinary Products Recent Developments/Updates
Table 72. Green Cross Veterinary Products Competitive Strengths & Weaknesses
Table 73. Harrisvaccines Basic Information, Manufacturing Base and Competitors
Table 74. Harrisvaccines Major Business
Table 75. Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 76. Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Harrisvaccines Recent Developments/Updates
Table 78. Harrisvaccines Competitive Strengths & Weaknesses
Table 79. Komipharm Basic Information, Manufacturing Base and Competitors
Table 80. Komipharm Major Business
Table 81. Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 82. Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Komipharm Recent Developments/Updates
Table 84. Komipharm Competitive Strengths & Weaknesses
Table 85. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 86. Nisseiken Major Business
Table 87. Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 88. Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Nisseiken Recent Developments/Updates
Table 90. Nisseiken Competitive Strengths & Weaknesses
Table 91. Qilu Animal Health Basic Information, Manufacturing Base and Competitors
Table 92. Qilu Animal Health Major Business
Table 93. Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 94. Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Qilu Animal Health Recent Developments/Updates
Table 96. Qilu Animal Health Competitive Strengths & Weaknesses
Table 97. Zoetis Basic Information, Manufacturing Base and Competitors
Table 98. Zoetis Major Business
Table 99. Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 100. Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Zoetis Recent Developments/Updates
Table 102. Zoetis Competitive Strengths & Weaknesses
Table 103. Wuhan Keqian Basic Information, Manufacturing Base and Competitors
Table 104. Wuhan Keqian Major Business
Table 105. Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 106. Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Wuhan Keqian Recent Developments/Updates
Table 108. Wuhan Keqian Competitive Strengths & Weaknesses
Table 109. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 110. China Animal Husbandry Industry Major Business
Table 111. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 112. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. China Animal Husbandry Industry Recent Developments/Updates
Table 114. China Animal Husbandry Industry Competitive Strengths & Weaknesses
Table 115. Luoyang Huizhong Basic Information, Manufacturing Base and Competitors
Table 116. Luoyang Huizhong Major Business
Table 117. Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 118. Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Luoyang Huizhong Recent Developments/Updates
Table 120. Luoyang Huizhong Competitive Strengths & Weaknesses
Table 121. Shanghai Hile Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 122. Shanghai Hile Bio-Technology Major Business
Table 123. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 124. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Shanghai Hile Bio-Technology Recent Developments/Updates
Table 126. Shanghai Hile Bio-Technology Competitive Strengths & Weaknesses
Table 127. Harbin Weike Basic Information, Manufacturing Base and Competitors
Table 128. Harbin Weike Major Business
Table 129. Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 130. Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Harbin Weike Recent Developments/Updates
Table 132. Harbin Weike Competitive Strengths & Weaknesses
Table 133. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 134. Harbin Pharmaceutical Group Major Business
Table 135. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 136. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Harbin Pharmaceutical Group Recent Developments/Updates
Table 138. Jiangsu Nannong Basic Information, Manufacturing Base and Competitors
Table 139. Jiangsu Nannong Major Business
Table 140. Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 141. Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Upstream (Raw Materials)
Table 143. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Typical Customers
Table 144. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Typical Distributors
Table 1. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share by Region (2018-2023)
Table 9. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share by Region (2024-2029)
Table 10. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Market Trends
Table 13. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Producers in 2022
Table 18. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Producers in 2022
Table 20. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Company Evaluation Quadrant
Table 22. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Site of Key Manufacturer
Table 24. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Company Product Type Footprint
Table 25. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market: Company Product Application Footprint
Table 26. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Competitive Factors
Table 27. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine New Entrant and Capacity Expansion Plans
Table 28. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share (2018-2023)
Table 37. China Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share (2018-2023)
Table 47. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. CAVAC Basic Information, Manufacturing Base and Competitors
Table 62. CAVAC Major Business
Table 63. CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 64. CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. CAVAC Recent Developments/Updates
Table 66. CAVAC Competitive Strengths & Weaknesses
Table 67. Green Cross Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 68. Green Cross Veterinary Products Major Business
Table 69. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 70. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Green Cross Veterinary Products Recent Developments/Updates
Table 72. Green Cross Veterinary Products Competitive Strengths & Weaknesses
Table 73. Harrisvaccines Basic Information, Manufacturing Base and Competitors
Table 74. Harrisvaccines Major Business
Table 75. Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 76. Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Harrisvaccines Recent Developments/Updates
Table 78. Harrisvaccines Competitive Strengths & Weaknesses
Table 79. Komipharm Basic Information, Manufacturing Base and Competitors
Table 80. Komipharm Major Business
Table 81. Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 82. Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Komipharm Recent Developments/Updates
Table 84. Komipharm Competitive Strengths & Weaknesses
Table 85. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 86. Nisseiken Major Business
Table 87. Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 88. Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Nisseiken Recent Developments/Updates
Table 90. Nisseiken Competitive Strengths & Weaknesses
Table 91. Qilu Animal Health Basic Information, Manufacturing Base and Competitors
Table 92. Qilu Animal Health Major Business
Table 93. Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 94. Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Qilu Animal Health Recent Developments/Updates
Table 96. Qilu Animal Health Competitive Strengths & Weaknesses
Table 97. Zoetis Basic Information, Manufacturing Base and Competitors
Table 98. Zoetis Major Business
Table 99. Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 100. Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Zoetis Recent Developments/Updates
Table 102. Zoetis Competitive Strengths & Weaknesses
Table 103. Wuhan Keqian Basic Information, Manufacturing Base and Competitors
Table 104. Wuhan Keqian Major Business
Table 105. Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 106. Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Wuhan Keqian Recent Developments/Updates
Table 108. Wuhan Keqian Competitive Strengths & Weaknesses
Table 109. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 110. China Animal Husbandry Industry Major Business
Table 111. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 112. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. China Animal Husbandry Industry Recent Developments/Updates
Table 114. China Animal Husbandry Industry Competitive Strengths & Weaknesses
Table 115. Luoyang Huizhong Basic Information, Manufacturing Base and Competitors
Table 116. Luoyang Huizhong Major Business
Table 117. Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 118. Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Luoyang Huizhong Recent Developments/Updates
Table 120. Luoyang Huizhong Competitive Strengths & Weaknesses
Table 121. Shanghai Hile Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 122. Shanghai Hile Bio-Technology Major Business
Table 123. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 124. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Shanghai Hile Bio-Technology Recent Developments/Updates
Table 126. Shanghai Hile Bio-Technology Competitive Strengths & Weaknesses
Table 127. Harbin Weike Basic Information, Manufacturing Base and Competitors
Table 128. Harbin Weike Major Business
Table 129. Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 130. Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Harbin Weike Recent Developments/Updates
Table 132. Harbin Weike Competitive Strengths & Weaknesses
Table 133. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 134. Harbin Pharmaceutical Group Major Business
Table 135. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 136. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Harbin Pharmaceutical Group Recent Developments/Updates
Table 138. Jiangsu Nannong Basic Information, Manufacturing Base and Competitors
Table 139. Jiangsu Nannong Major Business
Table 140. Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product and Services
Table 141. Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Upstream (Raw Materials)
Table 143. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Typical Customers
Table 144. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Picture
Figure 2. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029) & (K Units)
Figure 5. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029) & (K Units)
Figure 10. China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029) & (K Units)
Figure 12. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Markets in 2022
Figure 26. United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share 2022
Figure 32. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Type in 2022
Figure 34. Live Vaccine
Figure 35. Inactivated Vaccine
Figure 36. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Application in 2022
Figure 41. Piglet
Figure 42. Adult Pig
Figure 43. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Chain
Figure 47. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Procurement Model
Figure 48. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Model
Figure 49. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Picture
Figure 2. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029) & (K Units)
Figure 5. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029) & (K Units)
Figure 10. China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production (2018-2029) & (K Units)
Figure 12. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Markets in 2022
Figure 26. United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share 2022
Figure 32. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Type in 2022
Figure 34. Live Vaccine
Figure 35. Inactivated Vaccine
Figure 36. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Application in 2022
Figure 41. Piglet
Figure 42. Adult Pig
Figure 43. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Chain
Figure 47. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Procurement Model
Figure 48. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Model
Figure 49. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
